ruxolitinib
novartis,incyte
['ruxolitinib']
 asco 2023 oncologytube interview with dr. #davidpeereboom at , on the #crux clinical trial at #asco23. the study explores the potential of #ruxolitinib in treating high-grade gliomas. #braincancer 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.